{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:54:04Z","timestamp":1771628044813,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,4,1]],"date-time":"1993-04-01T00:00:00Z","timestamp":733622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1993,4]]},"DOI":"10.1007\/bf00400235","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T14:32:54Z","timestamp":1098282774000},"page":"323-328","source":"Crossref","is-referenced-by-count":21,"title":["Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits"],"prefix":"10.1007","volume":"36","author":[{"given":"G. T.","family":"Westermark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Christmanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Terenghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Permerth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Betsholtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Polak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Westermark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","volume":"140","author":"P Westermark","year":"1986","unstructured":"Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 827?831","journal-title":"Biochem Biophys Res Commun"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 3881?3885","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR3","first-page":"414","volume":"127","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987) Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Path 127: 414?417","journal-title":"Am J Path"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper GJ, Willis AC, Clark A, Turner AC, Sim RB, Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628?8632","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR5","first-page":"1","volume":"130","author":"KH Johnson","year":"1988","unstructured":"Johnson KH, O'Brien TD, Hayden DW et al. (1988) Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Path 130: 1?8","journal-title":"Am J Path"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00285291","volume":"32","author":"A Lukinius","year":"1989","unstructured":"Lukinius A, Wilander E, Westermark GT, Engstr\u00f6m U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32: 240?244","journal-title":"Diabetologia"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00221649","volume":"257","author":"A Clark","year":"1989","unstructured":"Clark A, Edwards CA, Ostle LR et al. (1989) Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects. Cell Tissue Res 257: 179?185","journal-title":"Cell Tissue Res"},{"key":"CR8","first-page":"1321","volume":"138","author":"G Rindi","year":"1991","unstructured":"Rindi G, Terenghi G, Westermark G, Westermark P, Moscoso G, Polak JM (1991) Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice. Am J Path 138: 1321?1334","journal-title":"Am J Path"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF00404025","volume":"34","author":"E Hartter","year":"1991","unstructured":"Hartter E, Svoboda T, Ludvik B et al. (1991) Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 34: 52?54","journal-title":"Diabetologia"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2337\/diab.39.6.752","volume":"39","author":"PC Butler","year":"1990","unstructured":"Butler PC, Chou J, Carter WB et al. (1990) Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752?756","journal-title":"Diabetes"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"SE Kahn","year":"1990","unstructured":"Kahn SE, D'Alessio DA, Schwartz MW et al. (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by b-cells. Diabetes 39: 634?638","journal-title":"Diabetes"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-291X(89)91732-4","volume":"164","author":"M Nakazato","year":"1989","unstructured":"Nakazato M, Asai J, Kangawa K, Matsukura S, Matsuo H (1989) Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration. Biochem Biophys Res Commun 164: 394?399","journal-title":"Biochem Biophys Res Commun"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00500385","volume":"34","author":"T Sanke","year":"1991","unstructured":"Sanke T, Hanabusa T, Nakano Y et al. (1991) Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34: 129?132","journal-title":"Diabetologia"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/mend-5-1-143","volume":"5","author":"OD Madsen","year":"1991","unstructured":"Madsen OD, Nielsen JH, Michelsen B et al. (1991) Islet amyloid polypeptide and insulin expression are controlled differently in primary and transformed islet cells. Mol Endocrinol 5: 143?148","journal-title":"Mol Endocrinol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"17243","DOI":"10.1016\/S0021-9258(19)77825-9","volume":"263","author":"T Sanke","year":"1988","unstructured":"Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF (1988) An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem 263: 17243?17246","journal-title":"J Biol Chem"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0014-4827(89)90407-2","volume":"183","author":"C Betsholtz","year":"1989","unstructured":"Betsholtz C, Svensson V, Rorsman F et al. (1989) Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with species-specific occurrence of age-related diabetes mellitus. Exp Cell Res 183: 484?493","journal-title":"Exp Cell Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0014-5793(89)81260-8","volume":"247","author":"S Mosselman","year":"1989","unstructured":"Mosselman S, H\u00f6ppener JWM, Lips CJM, Jansz HS (1989) The complete islet amyloid polypeptide precursor is encoded by two exons. FEBS Lett 247: 154?158","journal-title":"FEBS Lett"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/335632a0","volume":"335","author":"B Leighton","year":"1988","unstructured":"Leighton B, Cooper GJS (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632?635","journal-title":"Nature"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/bj2690019","volume":"269","author":"B Leighton","year":"1990","unstructured":"Leighton B, Foot E (1990) The effects of amylin on carbohydrate metabolism in skeletal muscle in vitro and in vivo. Biochem J 269: 19?23","journal-title":"Biochem J"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF00400848","volume":"35","author":"JR Zierath","year":"1992","unstructured":"Zierath JR, Galuska D, Engstr\u00f6m \u00c5 et al. (1992) Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol ester-stimulated glucose transport in in vitro incubated human muscle strips. Diabetologia 35: 26?31","journal-title":"Diabetologia"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-291X(90)92053-3","volume":"167","author":"KH Johnson","year":"1990","unstructured":"Johnson KH, O'Brien TD, Jordan K, Betsholtz C, Westermark P (1990) The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in cats. Biochem Biophys Res Commun 167: 507?513","journal-title":"Biochem Biophys Res Commun"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00401051","volume":"33","author":"R Sowa","year":"1990","unstructured":"Sowa R, Sanke T, Hirayama J et al. (1990) Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 33: 118?120","journal-title":"Diabetologia"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00401195","volume":"35","author":"P Westermark","year":"1992","unstructured":"Westermark P, Johnson KH, O'Brien TD, Betsholtz C (1992) Islet amyloid polypeptide ? a novel controversy in diabetes research. Diabetologia 35: 297?303","journal-title":"Diabetologia"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/BF00274799","volume":"30","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30: 887?892","journal-title":"Diabetologia"},{"key":"CR25","first-page":"245","volume":"135","author":"KH Johnson","year":"1989","unstructured":"Johnson KH, O'Brien TD, Jordan K, Westermark P (1989) Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells. Am J Path 135: 245?250","journal-title":"Am J Path"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF00251821","volume":"24","author":"P Westermark","year":"1983","unstructured":"Westermark P, Wilander E (1983) Islet amyloid in type 2 (non-insulin-dependent) diabetes is related to insulin. Diabetologia 24: 342?346","journal-title":"Diabetologia"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577?580","journal-title":"J Histochem Cytochem"},{"key":"CR28","volume-title":"Immunocytochemistry","author":"LA Sternberger","year":"1979","unstructured":"Sternberger LA (1979) Immunocytochemistry (2nd edn.). John Wiley, New York","edition":"2nd edn."},{"key":"CR29","first-page":"81","volume-title":"In situ hybridization. Principles and practice","author":"SJ Gibson","year":"1990","unstructured":"Gibson SJ, Polak JM (1990) Principles and applications of complementary RNA probes. In: Polak JM, McGee JO (eds) In situ hybridization. Principles and practice. Oxford University Press, Oxford, pp 81?94"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0012-1606(84)90162-3","volume":"101","author":"KH Cox","year":"1984","unstructured":"Cox KH, DeLeon DV, Angerer LM, Angerer RC (1984) Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Develop Biol 101: 485?502","journal-title":"Develop Biol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/path.1711650204","volume":"165","author":"K Shorrock","year":"1991","unstructured":"Shorrock K, Roberts P, Pringle JH, Lauder I (1991) Demonstration of insulin and glucagon mRNA in routinely fixed and processed pancreatic tissue by in-situ hybridization. J Path 165: 105?110","journal-title":"J Path"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P, Engstr\u00f6m U, Johnson KH, Westermark GT, Betsholtz C (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87: 5036?5040","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR33","first-page":"291","volume":"81","author":"P Westermark","year":"1973","unstructured":"Westermark P, Grimelius L (1973) The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Path Microbiol Scand A 81: 291?300","journal-title":"Acta Path Microbiol Scand A"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00400235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00400235\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00400235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T16:30:22Z","timestamp":1682785822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00400235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,4]]}},"alternative-id":["BF00400235"],"URL":"https:\/\/doi.org\/10.1007\/bf00400235","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,4]]}}}